{"abstract":"The Food and Drug Administration (FDA, the Agency, or we) is establishing a public docket to collect examples about how previous patient-focused drug development (PFDD) meetings have impacted stakeholders' drug development efforts. This includes impacts on community engagement, research priorities, advocacy strategies, medical product development programs, clinical practice, and other areas of interest.","action":"Notice; establishment of a public docket; request for information and comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/05/01/2026-08524.html","cfr_references":[],"citation":"91 FR 23426","comment_url":null,"comments_close_on":"2026-06-30","correction_of":null,"corrections":[],"dates":"Either electronic or written comments on the notice must be submitted by June 30, 2026","disposition_notes":null,"docket_ids":["Docket No. FDA-2026-N-3947"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":69,"comment_start_date":"2026-05-01","updated_at":"2026-07-22T01:56:50.981-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2026-N-3947-0001","allow_late_comments":false,"id":"FDA-2026-N-3947-0001","comment_end_date":"2026-07-01","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2026-N-3947","title":"Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments"}],"document_number":"2026-08524","effective_on":null,"end_page":23427,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/05/01/2026-08524.xml","html_url":"https://www.federalregister.gov/documents/2026/05/01/2026-08524/impacts-of-patient-focused-drug-development-meetings-establishment-of-a-public-docket-request-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-08524?publication_date=2026-05-01","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-05-01/2026-08524/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":2584,"last_updated":"2026-11-22 14:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-01/pdf/2026-08524.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-08524.pdf?1777553121","publication_date":"2026-05-01","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/05/01/2026-08524.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":69,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2026-N-3947","supporting_documents_count":0,"docket_id":"FDA-2026-N-3947","document_id":"FDA-2026-N-3947-0001","regulation_id_number":null,"title":"Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments","checked_regulationsdotgov_at":"2026-07-23T08:55:03Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":23426,"subtype":null,"title":"Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments","toc_doc":"Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket","toc_subject":"Request for Information","topics":[],"type":"Notice","volume":91}